Intracellular traffic to compartments for MHC class II peptide loading: Signals for endosomal and polarized sorting

Immunological Reviews

Volumn 172, Issue , 1999, Pages 171-187

  Bakke, Oddmund ^a   Nordeng, Tommy W ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; ENDOCYTOSIS; ENDOSOME; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 0033460141     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01365.x     Document Type: Article

References (208)

1. 1. Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993;11:403-450.
2. 2. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 1994;12:259-293.
3. 3. Nordeng TW, Gorvel J-P, Bakke O. Intracellular transport of molecules engaged in the presentation of exogenous antigen. Curr Top Microbiol Immunol 1998;232:179-215.
4. 4. Long EO. Intracellular traffic and antigen processing. Immunol Today 1989;10:232-234.
5. 5. Koch N, Lipp J, Pessara U, Schenck K, Wraight C, Dobberstein B. MHC class II invariant chains in antigen processing and presentation. Trends Biochem Sci 1989;14:383-386.
6. 6. Cresswell P. Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis. Proc Natl Acad Sci USA 1985;82:8188-8192.
7. 7. Blum JS, Cresswell P. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci USA 1988;85:3975-3979.
8. 8. Guagliardi LE, Koppelman B, Blum JS, Marks MS, Cresswell P, Brodsky FM. Colocalization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 1990;343:133-139.
9. 9. Pieters J, Horstmann H, Bakke O, Griffiths G, Lipp J. Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain. J Cell Biol 1991;115:1213-1223.
10. 10. Peters C, et al. Targeting of a lysosomal membrane protein: a tyrosine-containing endocytosis signal in the cytoplasmic tail of lysosomal acid phosphatase is necessary and sufficient for targeting to lysosomes. EMBO J 1990;9:3497-3506.
11. 11. Stockinger B, Pessara U, Lin RH, Habicht J, Grez M, Koch N. A role of Ia-associated invariant chains in antigen processing and presentation. Cell 1989;56:683-689.
12. 1 2. Bakke O, Dobberstein B. Searching for a sorting signal of the MHC class II molecule associated invariant chain. J Cell Biochem 1990; S14C: 37.
13. 13. Bakke O, Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990;63:707-716.
14. 14. Lotteau V, et al. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 1990;348:600-605.
15. 15. Simonsen A, Momburg F, Drexler J, Hämmerling GJ, Bakke O. Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines. Int Immunol 1993;5:903-917.
16. 16. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991;349:669-676.
17. 17. Tulp A, Verwoerd D, Dobberstein B, Ploegh HL, Pieters J. Isolation and characterization of the intracellular MHC class II compartment. Nature 1994;369:120-126.
18. 18. West MA, Lucocq JM, Watts C. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 1994;369:147-151.
19. 19. Amigorena S, Drake JR, Webster P, Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 1994;369:113-120.
20. 20. Qiu Y, Xu X, Wandinger-Ness A, Dalke DP, Pierce SK. Separation of subcellular compartments containing distinct functional forms of MHC class II. J Cell Biol 1994;125:595-605.
21. 21. Stang E, Guerra CB, Amaya M, Paterson Y, Bakke O, Mellins ED. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells. J Immunol 1998;160:4696-4707.
22. 22. Geuze HJ. The role of endosomes and lysosomes in MHC class II functioning. Immunol Today 1998;19:282-287.
23. 23. Sandoval IV, Bakke O. Targeting of membrane proteins to endosomes and lysosomes. Trends Cell Biol 1994;4:292-298.
24. 24. Schmid SL. Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu Rev Biochem 1997;66:511-548.
25. 25. Kirchhausen T, Bonifacino JS, Riezman H. Linking cargo to vesicle formation: receptor tail interactions with coat proteins. Curr Opin Cell Biol 1997;9:488-495.
26. 26. Lewin DA, Mellman I. Sorting out adaptors. Biochim Biophys Acta 1998;1401:129-145.
27. 27. Odorizzi G, Cowles CR, Emr SD. The AP-3 complex: a coat of many colours. Trends Cell Biol 1998;8:282-288.
28. 28. Ohno H, et al. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 1995;269:1872-1875.
29. 29. Rapoport I, et al. Regulatory interactions in the recognition of endocytic sorting signals by AP-2 complexes. EMBO J 1997;16:2240-2250.
30. 30. Dell'Angelica EC, Ohno H, Ooi CE, Rabinovich E, Roche KW, Bonifacino JS. AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO J 1997;16:917-928.
31. 31. Ohno H, Aguilar RC, Yeh D, Taura D, Saíto T, Bonifacino JS. The medium subunits of adaptor complexes recognize distinct but overlapping sets of tyrosine-based sorting signals. J Biol Chem 1998;273:25915-25921.
32. 32. Bremnes T, Lauvrak V, Lindqvist B, Bakke O. A region from the medium chain adaptor subunit (μ) recognizes leucine-and tyrosine-based sorting signals. J Biol Chem 1998;273:8638-8645.
33. 33. Rodionov DG, Bakke O. Medium chains of adaptor complexes AP-1 and AP-2 recognize leucine-based sorting signals from the invariant chain. J Biol Chem 1998;273:6005-6008.
34. 33a. Hofmann MW, Höning S, Rodionov D, Dobberstein B, von Figura K, Bakke O. The lencine-based sorting motifs in the cytoplasmic tail of invariant chain are recognized by the clathrin adaptors AP1 and AP2 in their medium chains: a plasmon resonance study. J Biol Chem (In press)
35. 34. Boll W, et al. Sequence requirements for the recognition of tyrosine-based endocytic signals by clathrin AP-2 complexes. EMBO J 1996;15:5789-5795.
36. 35. Marks MS, Ohno H, Kirchhausen T, Bonifacino SJ. Protein sorting by tyrosine-based signals: adapting to the Ys and wherefores. Trends Cell Biol 1997;7:124-128.
37. 36. Le Borgne R, Alconada A, Bauer U, Hoflack B. The mammalian AP-3 adaptor-like complex mediates the intracellular transport of lysosomal membrane glycoproteins. J Biol Chem 1998;273:29451-29461.
38. 37. Höning S, Sandoval IV, von Figura K. A di-leucine-based motif in the cytoplasmic tail of LIMP-II and tyrosinase mediates selective binding of AP-3. EMBO J 1998;17:1304-1314.
39. 38. Warren RA, Green FA, Enns CA. Saturation of the endocytic pathway for the transferrin receptor does not affect the endocytosis of the epidermal growth factor receptor. J Biol Chem 1997;272:2116-2121.
40. 39. Warren RA, Green FA, Stenberg PE, Enns CA. Distinct saturable pathways for the endocytosis of different tyrosine motifs. J Biol Chem 1998;273:17056-17063.
41. 40. Nordeng TW, Bakke O. Overexpression of proteins containing tyrosine-or leucine-based sorting signals affects transferrin receptor trafficking. J Biol Chem 1999;274:21139-21148.
42. 41. De Camilli P, Emr SD, McPherson PS, Novick P. Phosphoinositides as regulators in membrane traffic. Science 1996;271:1533-1539.
43. 42. Wendland B, Emr SD, Riezman H. Protein traffic in the yeast endocytic and vacuolar protein sorting pathways. Curr Opin Cell Biol 1998;10:513-522.
44. 43. Gaidarov I, Chen Q, Falck JR, Reddy KK, Keen JH. A functional phosphatidylinositol 3,4,5-trisphosphate/phosphoinositide binding domain in the clathrin adaptor AP-2 alpha subunit - implications for the endocytic pathway. J Biol Chem 1996;271:20922-20929.
45. 44. Roche PA, Teletski CL, Stang E, Bakke O, Long EO. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci USA 1993;90:8581-8585.
46. 45. Bremnes B, Madsen T, Gedde-Dahl M, Bakke O. An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J Cell Sci 1994;107:2021-2032.
47. 46. Neefjes JJ, Stollorz V, Peters PJ, Geuze HJ, Ploegh HL. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 1990;61:171-183.
48. 47. Harter C, Mellman I. Transport of the lysosomal membrane glycoprotein Igp120 (Igp-A) to lysosomes does not require appearance on the plasma membrane. J Cell Biol 1992;117:311-325.
49. 48. Johnson KF, Kornfeld S. The cytoplasmic tail of the mannose 6-phosphate/insulin-like growth factor-II receptor has two signals for lysosomal enzyme sorting in the Golgi. J Cell Biol 1992;119:249-257.
50. 49. Kang S, Liang L, Parker CD, Collawn JF. Structural requirements for major histocompatibility complex class II invariant chain endocytosis and lysosomal targeting. J Biol Chem 1998;273:20644-20652.
51. 50. Motta A, Bremnes B, Morelli MAC, Frank RW, Saviano G, Bakke O. Structure-activity relationship of the leucine-based sorting motifs in the cytosolic tail of the major histocompatibility complex-associated invariant chain. J Biol Chem 1995;270:27165-27171.
52. 51. Simonsen A, Bremnes B, Nordeng TW, Bakke O. The leucine-based motif (DDQxxLI) is recognized both for internalization and basolateral sorting of invariant chain in MDCK cells. Eur J Cell Biol 1998;76:25-32.
53. 52. Pond L, et al. A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway. J Biol Chem 1995;270:19989-19997.
54. 53. Odorizzi CG, Trowbridge IS, Xue L, Hopkins CR, Davis CD, Collawn JF. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J Cell Biol 1994;126:317-330.
55. 54. Karlsson L, Péléraux A, Lindstedt R, Liljedahl M, Peterson PA. Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 1994;166:1569-1573.
56. 55. Sanderson F, et al. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 1994;266:1566-1569.
57. 56. Lindstedt R, Liljedahl M, Peleraux A, Peterson PA, Karlsson L. The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity 1995;3:561-572.
58. 57. Salamero J, Humbert M, Cosson P, Davoust J. Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules. EMBO J 1990;9:3489-3496.
59. 58. Humbert M, et al. Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents. Eur J Immunol 1993;23:3167-3172.
60. 59. Chervonsky AV, Gordon L, Sant AJ. A segment of the MHC class II β chain plays a critical role in targeting class II molecules to the endocytic pathway. Int Immunol 1994;6:973-982.
61. 60. Tan LJ, Ceman S, Chervonsky A, Rodriguez-Paris J, Steck TL, Sant AJ. Late events in the intracellular sorting of major histocompatibility complex class II molecules are regulated by the 80-82 segment of the class II β chain. Eur J Immunol 1997;27:1479-1488.
62. 61. Reid PA, Watts C. Constitutive endocytosis and recycling of major histocompatibility complex class II glycoproteins in human B-lymphoblastoid cells. Immunology 1992;77:539-542.
63. 62. Pinet V, Vergelli M, Martin R, Bakke O, Long EO. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 1995;375:603-606.
64. 63. Smiley ST, Rudensky AY, Glimcher LH, Grusby MJ. Truncation of the class II beta-chain cytoplasmic domain influences the level of class II invariant chain-derived peptide complexes. Proc Natl Acad Sci USA 1996;93:241-244.
65. 64. Forquet F, et al. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules. J Immunol 1999;161:3408-3416.
66. 65. Nabavi N, et al. Antigen presentation abrogated in cells expressing truncated Ia molecules. J Immunol 1989;141:1444-1447.
67. 66. St-Pierre Y, Nabavi N, Ghogawala Z, Glimcher LH, Watts TH. A functional role for signal transduction via the cytoplasmic domains of MHC class II proteins. J Immunol 1989;143:808-812.
68. 67. Pinet V, Malnati MS, Long EO. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J Immunol 1994;151:4852-4860.
69. 68. Smiley ST, Laufer TM, Lo D, Glimcher LH, Grusby MJ. Transgenic mice expressing MHC class II molecules with truncated Aβ cytoplasmic domains reveal signaling-independent defects in antigen presentation. Int Immunol 1995;7:665-677.
70. 69. Simonsen A, et al. Polarized transport of MHC class II molecules in MDCK cells is directed by a leucine-based signal in the cytoplasmic tail of the b chain. J Immunol 1999;163:2540-2548.
71. 70. Zhong GM, Romagnoli P, Germain RN. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J Exp Med 1997;185:429-438.
72. 71. Bonnerot C, et al. Role of B cell receptor Ig-α and Ig-β subunits in MHC class II-restricted antigen presentation. Immunity 1995;3:335-347.
73. 72. Davidson HW, West MA, Watts C. Endocytosis, intracellular trafficking, and processing of membrane IgG and monovalent antigen/membrane IgG complexes in B lymphocytes. J Immunol 1990;144:4101-4109.
74. 73. Knight AM, Lucocq JM, Prescott AR, Ponnambalam S, Watts C. Antigen endocytosis and presentation mediated by human membrane IgG1 in the absence of the Igα/Igβ dimer. EMBO J 1997;16:3842-3850.
75. 74. Weiser P, Müller R, Braun U, Reth M. Endosomal targeting and the cytoplasmic tail of membrane immunoglobulin: retraction. Science 1997;277:20-21.
76. 75. Bonnerot C, Amigorena S, Choquet D, Pavlovich R, Choukroun V, Fridman WH. Role of associated γ-chain in tyrosine kinase activation via murine Fcγ RIII. EMBO J 1992;11:2747-2757.
77. 76. Daëron M, Malbec O, Latour S, Bonnerot C, Segal DM, Fridman WH. Distinct intracytoplasmic sequences are required for endocytosis and phagocytosis via murine Fcγ RII in mast cells. Int Immunol 1993;5:1393-1401.
78. 77. Amigorena S, Lankar D, Briken V, Gapin L, Viguier M, Bonnerot C. Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens. J Exp Med 1998;187:505-515.
79. 78. Berg T, Gjøen T, Bakke O. Physiological functions of endosomal proteolysis. Biochem J 1995;307:313-326.
80. 79. Stahl PD, Ezekowitz RA. The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 1998;10:50-55.
81. 80. Tan MCAA, et al. Mannose receptor mediated uptake of antigens strongly enhances HLA-class II restricted antigen presentation by cultured dendritic cells. Adv Exp Med Biol 1997;417:171-174.
82. 81. Engering AJ, Cella M, Fluitsma DM, Hoefsmit ECM, Lanzavecchia A, Pieters J. Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv Exp Med Biol 1997;417:183-187.
83. 82. Engering A, Lefkovits I, Pieters J. Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis. Electrophoresis 1997;18:2523-2530.
84. 83. Raposo G, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183:1161-1172.
85. 84. Wubbolts R, et al. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J Cell Biol 1996;135:611-622.
86. 85. Pond L, Watts C. Characterization of transport of newly assembled, T cell-stimulatory MHC class II peptide complexes from MHC class II compartments to the cell surface. J Immunol 1997;159-.543-553.
87. 86. Sadegh-Nasseri S, Germain RN. A role for peptide in determining MHC class II structure. Nature 1991;353:167-170.
88. 87. Wettstein DA, Boniface JJ, Reay PA, Schild H, Davis MM. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J Exp Med 1991;174:219-228.
89. 88. Germain RN, Hendrix LR. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 1991;353:134-139.
90. 89. Neefjes JJ, Ploegh HL. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance α/β heterodimers in endosomes. EMBO J 1992;11:411-416.
91. 90. Thery C, et al. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the α-and β-chains. J Immunol 1998;161:2106-2113.
92. 91. Simons K, Fuller SD. Cell surface polarity in epithelia. Annu Rev Cell Biol 1985;1:243-288.
93. 92. Rodriguez-Boulan E, Nelson WJ. Morphogenesis of the polarized epithelial cell phenotype. Science 1989;245:718-725.
94. 93. Van Eijkeren MA, Peters PJ, Geuze HJ. Polarized expression of major histocompatibility complex class I molecules in human endometrial and endocervical epithelial cells. Eur J Immunol 1991;21:3049-3052.
95. 94. Boudier JA, Fantini J, Gerard C, Verrier B. Polarized distribution of γ interferon-stimulated MHC antigens and transferrin receptors in a clonal cell line isolated from Fisher rat thyroid (FRT cells). Cell Tissue Res 1993;272:23-31.
96. 93. Selby WS, Janossy G, Goldstein G, Jewell DP. T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens. Clin Exp Immunol 1981;44:453-458.
97. 96. Hart DN, Fuggle SV, Williams KA, Fabre JW, Ting A, Morris PJ. Localization of HLA-ABC and DR antigens in human kidney. Transplantation 1981;31:428-433.
98. 97. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russell PS. Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by γ interferon. J Exp Med 1985;162:1645-1664.
99. 98. Bland PW, Warren LG. Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera. Immunology 1986;58:1-7.
100. 99. Sarles J, Gorvel JP, Olive D, Maroux S, Mawas C, Giraud F. Subcellular localization of class I (A,B,C) and class II (DR and DQ) MHC antigens in jejunal epithelium of children with coeliac disease. J Pediatr Gastroenterol Nutr 1987;6:51-56.
101. 100. Hershberg RM, et al. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J Clin Invest 1997;100:204-215.
102. 101. Hershberg RM, et al. Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J Clin Invest 1998;102:792-803.
103. 102. Mayrhofer G. Absorption and presentation of antigens by epithelial cells of the small intestine: hypotheses and predictions relating to the pathogenesis of coeliac disease. Immunol Cell Biol 1995;73:433-439.
104. 103. Prabhala RH, Wira CR. Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J Immunol 1995;155:5566-5573.
105. 104. Wira CR, Rossoll RM. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology 1995;84:505-508.
106. 105. Kelley VR, Singer GG. The antigen presentation function of renal tubular epithelial cells. Exp Nephrol 1993;1:102-111.
107. 106. Simonsen A, Stang E, Bremnes B, Roe M, Prydz K, Bakke O. Sorting of MHC class II molecules and the associated invariant chain (Ii) in polarized MDCK cells. J Cell Sci 1997;110:597-609.
108. 107. Gorvel JP, Sarles J, Maroux S, Olive D, Mawas C. Cellular localization of class I (HLA-A, B, C) and class II (HLA-DR and DQ) MHC antigens on the epithelial cells of normal human jejunum. Biol Cell 1984;52:249-252.
109. 108. Wandinger-Ness A, Bennett MK, Antony C, Simons K. Distinct transport vesicles mediate the delivery of plasma membrane proteins to the apical and basolateral domains of MDCK cells. J Cell Biol 1990;111:987-1000.
110. 109. Mellman I, Yamamoto E, Whitney JA, Kim M, Hunziker W, Matter K. Molecular sorting in polarized and non-polarized cells: common problems, common solutions. J Cell Sci 1993;106 (Suppl 17):1-7.
111. 110. Mellman I. Endocytosis and molecular sorting. Annu Rev Cell Biol 1996;12:575-625.
112. 111. Mostov KE, Cardone MH. Regulation of protein traffic in polarized epithelial cells. Bioessays 1995;17:129-138.
113. 112. Aroeti B, Mostov KE. Polarized sorting of the polymeric immunoglobulin receptor in the exocytotic and endocytotic pathways is controlled by the same amino acids. EMBO J 1994;13:2297-2304.
114. 113. Lehmann LE, et al. The internalization signal in the cytoplasmic tail of lysosomal acid phosphatase consists of the hexapeptide PGYRHV. EMBO J 1992;11:4391-4399.
115. 114. Matter K, Hunziker W, Mellman I. Basolateral sorting of LDL receptor in MDCK cells: the cytoplasmic domain contains two tyrosine-dependent targeting determinants. Cell 1992;71:741-753.
116. 115. Prill V, Lehmann L, von Figura K, Peters C. The cytoplasmic tail of lysosomal acid phosphatase contains overlapping but distinct signals for basolateral sorting and rapid internalization in polarized MDCK cells. EMBO J 1993;12:2181-2193.
117. 116. Matter K, Yamamoto EM, Mellman I. Structural requirements and sequence motifs for polarized sorting and endocytosis of LDL and Fc receptors in MDCK cells. J Cell Biol 1994;126:991-1004.
118. 117. Voorhees P, et al. An acidic sequence within the cytoplasmic domain of furin functions as a determinant of trans-Golgi network localization and internalization from the cell surface. EMBO J 1995;14:4961-4975.
119. 118. Mauxion F, Le Borgne R, Munier-Lehmann H, Hoflack B. A casein kinase II phosphorylation site in the cytoplasmic domain of the cation-dependent mannose 6-phosphate receptor determines the high affinity interaction of the AP-1 Golgi assembly proteins with membranes. J Biol Chem 1996;271:2171-2178.
120. 119. Ohno H, et al. Mu 1B, a novel adaptor medium chain expressed in polarized epithelial cells. FEBS Lett 1999;449:215-220.
121. 120. Musch A, Xu HX, Shields D, Rodriguez-Boulan E. Transport of vesicular stomatitis virus G protein to the cell surface is signal mediated in polarized and nonpolarized cells. J Cell Biol 1996;133:543-558.
122. 121. Yoshimori T, Keller P, Roth MG, Simons K. Different biosynthetic transport routes to the plasma membrane in BHK and CHO cells. J Cell Biol 1996;133:247-256.
123. 122. Lanzavecchia A. Mechanisms of antigen uptake for presentation. Curr Opin Immunol 1996;8:348-354.
124. 123. Bonnerot C, Briken V, Amigorena S. Intracellular signaling and endosomal trafficking of immunoreceptors shared effectors underlying MHC class II-restricted antigen presentation. Immunol Lett 1997;57:1-4.
125. 124. Amigorena S, Bonnerot C. Role of B-cell and Fc receptors in the selection of T-cell epitopes. Curr Opin Immunol 1998;10:88-92.
126. 125. Zimmermann VS, et al. Engagement of B cell receptor regulates the invariant chain-dependent MHC class II presentation pathway. J Immunol 1999;162:2495-2502.
127. 126. Siemasko K, et al. Igα and Igβ are required for efficient trafficking to late endosomes and to enhance antigen presentation. J Immunol 1999;162:6518-6525.
128. 127. Miettinen HM, Matter K, Hunziker W, Rose JK, Mellman I. Fc receptor endocytosis is controlled by a cytoplasmic domain determinant that actively prevents coated pit localization. J Cell Biol 1992;116:875-888.
129. 128. Amigorena S, Salamero J, Davoust J, Fridman WH, Bonnerot C. Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG. Nature 1992;358:337-341.
130. 129. Siemasko K, Eisfelder BJ, Williamson E, Kabak S, Clark MR. Signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. J Immunol 1998;160:5203-5208.
131. 130. Barois N, Forquet F, Davoust J. Selective modulation of the major histocompatibility complex class II antigen presentation pathway following B cell receptor ligation and protein kinase C activation. J Biol Chem 1997;272:3641-3647.
132. 131. Lankar D, et al. Syk tyrosine kinase and B cell antigen receptor (BCR) immunoglobulin-α subunit determine BCR-mediated major histocompatibility complex class II-restricted antigen presentation. J Exp Med 1998;188:819-831.
133. 132. Bonnerot C, et al. syk protein tyrosine kinase regulates Fc receptor γ-chain-mediated transport to lysosomes. EMBO J 1998;17:4606-4616.
134. 133. Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 1996;5:591-604.
135. 134. Simonsen A, et al. EEA 1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature 1998;394:494-498.
136. 135. Fernandez-Borja M, et al. Multivesicular body morphogenesis requires phosphatidyl-inositol 3-kinase activity. Curr Biol 1999;9:55-58.
137. 136. Araki N, Johnson MT, Swanson JA. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 1996;135:1249-1260.
138. 137. Carrasco-Marín E, Alvarez-Domínguez C, Leyva-Cobián F. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation. Eur J Immunol 1994;24:2031-2039.
139. 138. Song WX, Wagle NM, Banh T, Whiteford CC, Ulug E, Pierce SK. Wortmannin, a phosphatidylinositol 3-kinase inhibitor, blocks the assembly of peptide-MHC class II complexes. Int Immunol 1997;9:1709-1722.
140. 139. Barois N, Forquet F, Davoust J. Actin microfilaments control the MHC class II antigen presentation pathway in B cells. J Cell Sci 1998;111:1791-1800.
141. 140. McCoy KL, Gainey D, Inman JK, Stutzman R. Antigen presentation by B lymphoma cells: requirements for processing of exogenous antigen internalized through transferrin receptors. J Immunol 1993;151:4583-4594.
142. + T cells. J Immunol 1993;150:1691-1704.
143. 142. Gagliardi M-C, Nisini R, Benvenuto R, De Petrillo G, Michel M-L, Barnaba V. Soluble transferrin mediates targeting of hepatitis B envelope antigen to transferrin receptor and its presentation by activated T cells. Eur J Immunol 1994;24:1372-1376.
144. 143. Griffin JP, Chu R, Harding CV. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J Immunol 1997;158:1523-1532.
145. 144. Pinet VM, Long EO. Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur J Immunol 1998;28:799-804.
146. 145. Sekaly RP, Tonnelle C, Strubin M, Mach B, Long EO. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J Exp Med 1986;164:1490-1504.
147. 146. Miller J, Germain RN. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J Exp Med 1986;164:1478-1489.
148. 147. Anderson MS, Swier K, Arneson L, Miller J. Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J Exp Med 1993;178:1959-1969.
149. 148. Nijenhuis M, et al. Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling. Eur J Immunol 1994;24:873-883.
150. 149. St-Pierre Y, Watts TH. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A. J Immunol 1990;145:812-818.
151. 150. Kakiuchi T, Takatsuki A, Watanabe M, Nariuchi H. Inhibition by brefeldin A of the specific B cell antigen presentation to MHC class II-restricted T cells. J Immunol 1991;147:3289-3295.
152. 151. Swier K, Miller J. Invariant chain-independent antigen presentation depends primarily upon the pool of newly synthesized MHC class II molecules. J Immunol 1995;155:1851-1861.
153. 152. Nguyen QV, Humphreys RE. Time course of intracellular associations, processing, and cleavages of Ii forms and class II major histocompatibility complex molecules. J Biol Chem 1989;264:1631-1637.
154. 153. Newcomb JR, Cresswell P. Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo. J Immunol 1993;151:4153-4163.
155. 154. Xu M, Capraro GA, Daibata M, Reyes VE, Humphreys RE. Cathepsin B cleavage and release of invariant chain from MHC class II molecules follow a staged pattern. Mol Immunol 1994;31:723-731.
156. 155. Bracher V, Raposo G, Amigorena S, Mellman I. Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J Cell Biol 1997;137:51-65.
157. 156. Roche PA, Cresswell P. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci USA 1991;88:3150-3154.
158. 157. Daibata M, Xu M, Humphreys RE, Reyes VE. More efficient peptide binding to MHC class II molecules during cathepsin B digestion of Ii than after Ii release. Mol Immunol 1994;31:255-260.
159. 158. Maric MA, Taylor MD, Blum JS. Endosomal aspartic proteinases are required for invariant-chain processing. Proc Natl Acad Sci USA 1994;91:2171 -2175.
160. 159. Amigorena S, Webster P, Drake J, Newcomb J, Cresswell P, Mellman I. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J Exp Med 1995;181-1729-1741.
161. 160. Saleem M, Sawyer GJ, Schofield RA, Seymour ND, Gustafsson K, Fabre JW. Discordant expression of major histocompatibility complex class II antigens and invariant chain in interstitial dendritic cells - implications for self-tolerance and immunity. Transplantation 1997;63:1134-1138.
162. 161. Pierre P, et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997;388:787-792.
163. 162. Cella M, Engering A, Pinet V. Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997;388:782-787.
164. 163. Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998;93:1135-1145.
165. 164. Germain RN, et al. Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules. Immunol Rev 1996;151:5-30.
166. 165. Nordeng TW, Simonsen A, Bakke O. The various roles of invariant chain in the act of antigen presentation. In: Op den Kamp JAF, ed. Molecular dynamics of biomembranes. Berlin, Heidelberg: Springer-Verlag; 1996. p. 15-41.
167. 166. Romagnoli P, Layer C, Yewdell J, Bakke O, Germain RN. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J Exp Med 1993;177:583-596.
168. 167. Pieters J, Bakke O, Dobberstein B. The MHC class II associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J Cell Sci 1993;106:831-846.
169. 168. Arunachalam B, Lamb CA, Cresswell P. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int Immunol 1994;6:439-451.
170. 169. Sugita M, Brenner MB. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J Biol Chem 1995;270:1443-1448.
171. 170. Gedde-Dahl M, Freisewinkel I, Staschewski M, Schenck K, Koch N, Bakke O. Exon 6 is essential for invariant chain trimerization and induction of large endosomal structures. J Biol Chem 1997;272:8281-8287.
172. 171. Stang E, Bakke O. MHC class II associated invariant chain induced enlarged endosomal structures. A morphological study. Exp Cell Res 1997;235:79-82.
173. 172. Gorvel J-P, Escola J-M, Stang E, Bakke O. Invariant chain induces a delayed transport from early to late endosomes. J Biol Chem 1995;270:2741-2746.
174. 173. Loss GE Jr, Sant AJ. Invariant chain retains MHC class II molecules in the endocytic pathway. J Immunol 1993;150:3187-3197.
175. 174. Mu F-T, et al. EEA 1, an early endosome-associated protein. EEA 1 is a conserved α-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif. J Biol Chem 1995;270:13503-13511.
176. 175. Motta A, Amodeo P, Fucile P, Castiglione Morelli MA, Bremnes B, Bakke O. A new triple-stranded α-helical bundle in solution: the assembly of the cytosolic tail of MHC-associated invariant chain. Structure 1997;5:1453-1464.
177. 176. Papini E, et al. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc Natl Acad Sci USA 1994;91:9720-9724.
178. 177. Molinari M, et al. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers. J Biol Chem 1997;272:25339-25344.
179. 178. Molinari M, et al. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med 1998;187:135-140.
180. 179. Marks MS, Blum JS, Cresswell P. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J Cell Biol 1990;111:839-855.
181. 180. Bijlmakers ME, Benaroch P, Ploegh HL. Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J Exp Med 1994;180:623-629.
182. 181. Jasanoff A, Wagner G, Wiley DC. Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii. EMBO J 1998;17:6812-6818.
183. 181. Newcomb JR, Carboy-Newcomb C, Cresswell P. Trimeric interactions of the invariant chain and its association with major histocompatibility complex class II αβ dimers. J Biol Chem 1996;271:24249-24256.
184. 183. Bertolino P, et al. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation. J Immunol 1995;154:5620-5619.
185. 184. Arneson LS, Miller J. Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence. J Cell Biol 1995;129:1217-1228.
186. 185. Kuwana T, Peterson PA, Karlsson L. Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation. Proc Natl Acad Sci USA 1998;95:1056-1061.
187. 186. Anderson HA, Roche PA. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments. J Immunol 1998;160:4850-4858.
188. 187. Katunuma N, Kakegawa H, Matsunaga Y, Saibara T. Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family. FEBS Lett 1994;349:265-269.
189. 188. Ogrinc T, Dolenc I, Ritonja A. Turk V. Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney. FEBS Lett 1993;336:555-559.
190. 189. Fineschi B, Sakaguchi K, Appella E, Miller J. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain. J Immunol 1996;157:3211-3215.
191. 190. Bevec T, Stoka V, Pungercic G, Cazzulo JJ, Turk V. A fragment of the major histocompatibility complex class II -associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi. FEBS Lett 1997;401:259-261.
192. 191. Zachgo S, Dobberstein B, Griffiths G. A block in degradation of MHC class II-associated invariant chain correlates with a reduction in transport from endosome carrier vesicles to the prelysosome compartment. J Cell Sci 1992;103:811-822.
193. 192. Weiser P, Müller R, Braun U, Reth M. Endosomal targeting by the cytoplasmic tail of membrane immunoglobulin. Science 1997;276:407-409.
194. 193. Cassard S, et al. A tyrosine-based signal present in Ig α mediates B cell receptor constitutive internalization. J Immunol 1998;160:1767-1773.
195. 194. Patel KJ, Neuberger MS. Antigen presentation by the B cell antigen receptor is driven by the α/ β sheath and occurs independently of its cytoplasmic tyrosines. Cell 1993;74:939-946.
196. 195. Hunziker W, Fumey C. A dí-leucine motif mediates endocytosis and basolateral sorting of macrophage IgG Fc receptors in MDCK cells. EMBO J 1994;13:2963-2969.
197. 196. Stefaner I, Praetor A, Hunziker W. Nonvectorial surface transport, endocytosis via a di-leucine-based motif, and bidirectional transcytosis of chimera encoding the cytosolic tail of rat FcRn expressed in Madin-Darby canine kidney cells. J Biol Chem 1999;274:8998-9005.
198. 197. Ellinger I, Schwab M, Stefanescu A, Hunziker W, Fuchs R. IgG transport across trophoblast-derived BeWo cells: a model system to study IgG transport in the placenta. Eur J Immunol 1999;29:733-744.
199. 198. Praetor A, Ellinger I, Hunziker W. Intracellular traffic of the MHC class I-like IgG Fc receptor, FcRn, expressed in epithelial MDCK cells. J Cell Sci 1999;112:2291-2299.
200. 199. Kruskal BA, Sastry X, Warner AB, Mathieu CE, Ezekowitz RA. Phagocytic chimeric receptors require both transmembrane and cytoplasmic domains from the mannose receptor. J Exp Med 1992;176:1673-1680.
201. 200. Prydz K, Brandli AW, Bomsel M, Simons K. Surface distribution of the mannose 6-phosphate receptors in epithelial Madin-Darby canine kidney cells. J Biol Chem 1990;265:12629-12635.
202. 201. Johnson KF, Chan W, Kornfeld S. Cation-dependent mannose 6-phosphate receptor contains two internalization signals in its cytoplasmic domain [published erratum appears in Proc Natl Acad Sci USA 1991;88:1591]. Proc Natl Acad Sci USA 1990;87:10010-10014.
203. 202. Johnson KF, Kornfeld S. A His-Leu-Leu sequence near the carboxyl terminus of the cytoplasmic domain of the cation-dependent mannose 6-phosphate receptor is necessary for the lysosomal enzyme sorting function. J Biol Chem 1992;267:17110-17115.
204. 203. Chen HJ, Remmler J, Delaney JC, Messner DJ, Lobel P. Mutational analysis of the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor. J Biol Chem 1993;268:22338-22346.
205. 204. Distel B, Bauer U, Le Borgne R, Hoflack B. Basolateral sorting of the cation-dependent mannose 6-phosphate receptor in Madin-Darby canine kidney cells -identification of a basolateral determinant unrelated to clathrin-coated pit localization signals. J Biol Chem 1998;273:186-193.
206. 205. Odorizzi G, Trowbridge IS. Structural requirements for major histocompatibility complex class II invariant chain trafficking in polarized Madin-Darby canine kidney cells. J Biol Chem 1997;272:11757-11762.
207. 206. Copier J, et al. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB. J Immunol 1996;157:1017-1027.
208. 207. Marks MS, Roche PA, Van Donselaar E, Woodruff L, Peters PJ, Bonifacino JS. A lysosomal targeting signal in the cytoplasmic tail of the β chain directs HLA-DM to MHC class II compartments. J Cell Biol 1995;131:351-369.